BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28917574)

  • 1. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
    Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
    Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
    Ferguson NN; Asarch A; VanBeek M; Swick BL
    Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
    Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
    Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erosion of psoriatic plaques: an early sign of methotrexate toxicity.
    Pearce HP; Wilson BB
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 2):835-8. PubMed ID: 8912599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose methotrexate induced asymptomatic keratinocyte dystrophy in a patient of psoriasis vulgaris.
    Behera B; Kumari R; Gochhait D; Thappa DM
    J Cutan Pathol; 2016 Dec; 43(12):1238-1241. PubMed ID: 27714834
    [No Abstract]   [Full Text] [Related]  

  • 7. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.
    Hani N; Casper C; Groth W; Krieg T; Hunzelmann N
    Eur J Dermatol; 2000; 10(7):548-50. PubMed ID: 11056429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
    Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute methotrexate toxicity in psoriasis].
    Arévalo-López A
    Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple toxic effects of low-dose methotrexate in a patient treated for psoriasis.
    Bookstaver PB; Norris L; Rudisill C; DeWitt T; Aziz S; Fant J
    Am J Health Syst Pharm; 2008 Nov; 65(22):2117-21. PubMed ID: 18997139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate toxicity presenting as cutaneous ulcerations on psoriatic plaques.
    Koçak AY; Koçak O; Aslan F; Tektaş M
    Cutan Ocul Toxicol; 2013 Oct; 32(4):333-5. PubMed ID: 23537374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucocutaneous ulcerations secondary to methotrexate.
    Warner J; Brown A; Whitmore SE; Cowan DA
    Cutis; 2008 May; 81(5):413-6. PubMed ID: 18543592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflamed psoriatic plaques: drug toxicity or disease exacerbation?
    Jindal N; Arora K; Jindal P; Jain VK; Ghosh S
    Indian J Pharmacol; 2013; 45(4):410-1. PubMed ID: 24014924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerations due to methotrexate toxicity in a psoriasis patient.
    Souza CF; Suarez OM; Silva TF; Gorenstein AC; Quintella LP; Avelleira JC
    An Bras Dermatol; 2016; 91(3):375-7. PubMed ID: 27438211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [4pp Mucocutaneous manifestations of methotrexate toxicity].
    Ferrari B; Kogan N; Veira RC; Luna PC; Larralde M; Cuesta MG; Díaz P; Rossi MV; Aloise I
    Medicina (B Aires); 2018; 78(1):50-53. PubMed ID: 29360079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's lymphoma in a patient of psoriasis treated with long-term, low-dose methotrexate therapy.
    Khopkar U; Bhor U
    Indian J Dermatol Venereol Leprol; 2008; 74(4):379-82. PubMed ID: 18797063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucocutaneous Ulcerations and Pancytopenia due to Methotrexate Overdose.
    Knoll K; Anzengruber F; Cozzio A; French LE; Murer C; Navarini AA
    Case Rep Dermatol; 2016; 8(3):287-293. PubMed ID: 27920680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report.
    Kamangar F; Berger TG; Fazel N; Koo JY
    Cutis; 2013 Sep; 92(3):148-50. PubMed ID: 24153144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.